A Phase 2 Clinical Trial of Panitumumab Monotherapy in Japanese Patients with Metastatic Colorectal Cancer
Posted on April 28, 2009
Conclusions Panitumumab monotherapy was active in Japanese patients with chemotherapy-refractory mCRC, with pharmacokinetic and safety profiles similar to those seen in prior studies. (Source: Japanese Journal of Clinical Oncology)Tags: acne treatment, acne treatments, acne cure, get rid of acne, best acne treatment, acne free, acne skin care, acne solution, acne products, acne control
Comments
Leave a Comment
If you would like to make a comment, please fill out the form below.
You must be logged in to post a comment.